PortfoliosLab logo
Invivyd Inc. (IVVD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date

Aug 6, 2021

Highlights

Market Cap

$101.70M

EPS (TTM)

-$1.19

Total Revenue (TTM)

$36.69M

Gross Profit (TTM)

$34.24M

EBITDA (TTM)

-$145.63M

Year Range

$0.36 - $2.74

Target Price

$4.93

Short %

11.15%

Short Ratio

3.33

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Invivyd Inc. (IVVD) returned 111.01% year-to-date (YTD) and -48.34% over the past 12 months.


IVVD

YTD

111.01%

1M

48.41%

6M

33.84%

1Y

-48.34%

3Y*

-31.90%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.51%

1M

6.15%

6M

-2.00%

1Y

12.92%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of IVVD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-19.21%224.02%-47.84%4.13%48.41%111.01%
202421.07%-17.61%12.98%-50.00%-17.12%-40.22%13.64%-31.98%19.97%-12.50%-21.73%-36.57%-88.75%
202352.00%-23.68%-31.03%-8.33%63.64%-41.67%40.95%25.68%-8.60%-7.06%-3.16%157.52%162.67%
2022-1.10%-6.82%-31.84%-37.28%3.50%10.81%7.32%29.55%-31.36%26.20%-42.78%-33.63%-79.34%
202162.07%24.82%-30.78%60.88%-84.57%-65.23%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IVVD is 47, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of IVVD is 4747
Overall Rank
The Sharpe Ratio Rank of IVVD is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of IVVD is 7474
Sortino Ratio Rank
The Omega Ratio Rank of IVVD is 6969
Omega Ratio Rank
The Calmar Ratio Rank of IVVD is 2020
Calmar Ratio Rank
The Martin Ratio Rank of IVVD is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Invivyd Inc. (IVVD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Invivyd Inc. Sharpe ratios as of May 31, 2025 (values are recalculated daily):

  • 1-Year: -0.20
  • All Time: -0.30

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Invivyd Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History


Invivyd Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Invivyd Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Invivyd Inc. was 99.36%, occurring on Jan 31, 2025. The portfolio has not yet recovered.

The current Invivyd Inc. drawdown is 98.33%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.36%Sep 17, 2021847Jan 31, 2025
-20.22%Sep 13, 20211Sep 13, 20212Sep 15, 20213
-8.76%Aug 13, 20211Aug 13, 20216Aug 23, 20217
-6.87%Aug 24, 20213Aug 26, 20211Aug 27, 20214
-1.51%Sep 7, 20211Sep 7, 20211Sep 8, 20212
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Invivyd Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Invivyd Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -1,300.0%.


-1.00-0.80-0.60-0.40-0.200.00JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
-0.14
-0.01
Actual
Estimate

Valuation

The Valuation section provides an overview of how Invivyd Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for IVVD relative to other companies in the Biotechnology industry. Currently, IVVD has a P/S ratio of 2.8. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for IVVD in comparison with other companies in the Biotechnology industry. Currently, IVVD has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items